Long-term outcome of patients with end stage chronic kidney disease taking low-dose aspirin
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: CHEN, Chung-Yu (Kaohsiung, China Taiwan)
- Co-author(s): Huang, Yaw-Bin (Graduate Institute of Clinical Pharmacy, Kaohsiung, China Taiwan)
There are some data indicated that low-dose of aspirin using to be ineffective for ischemic stroke prevention on end stage chronic kidney disease (ESRD) patients. Therefore, we try to investigative the association of low-dose aspirin in terms of preventing death and readmission of stroke.
This retrospective study identified.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.